Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Venetoclax in Acute Myeloid Leukemia: NCT07075016 Clinical Landscape Report 2026
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07075016 Clinical Landscape Report 2026
15 October 2026
NCT07075016 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
KLN-1010 in Relapse multiple myeloma: NCT07075185 Clinical Landscape Report 2026
9 min read
KLN-1010 in Relapse multiple myeloma: NCT07075185 Clinical Landscape Report 2026
15 October 2026
NCT07075185 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Psilocybin in Adjustment disorders: NCT07072728 Clinical Landscape Report 2026
9 min read
Psilocybin in Adjustment disorders: NCT07072728 Clinical Landscape Report 2026
15 October 2026
NCT07072728 clinical landscape for Adjustment disorders: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Venetoclax in Acute Myeloid Leukemia: NCT07078591 Clinical Landscape Report 2026
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07078591 Clinical Landscape Report 2026
15 October 2026
NCT07078591 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Ocrelizumab in Multiple Sclerosis: NCT07074886 Clinical Landscape Report 2026
9 min read
Ocrelizumab in Multiple Sclerosis: NCT07074886 Clinical Landscape Report 2026
15 October 2026
NCT07074886 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tirzepatide in Endometrioid intraepithelial neoplasia: NCT07078838 Clinical Landscape Report 2026
9 min read
Tirzepatide in Endometrioid intraepithelial neoplasia: NCT07078838 Clinical Landscape Report 2026
15 October 2026
NCT07078838 clinical landscape for Endometrioid intraepithelial neoplasia: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
[225Ac]Ac-A9-3408 in Uveal Melanoma: NCT07076550 Clinical Landscape Report 2026
9 min read
[225Ac]Ac-A9-3408 in Uveal Melanoma: NCT07076550 Clinical Landscape Report 2026
15 October 2026
NCT07076550 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Venetoclax in Acute Myeloid Leukemia: NCT07082452 Clinical Landscape Report 2026
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07082452 Clinical Landscape Report 2026
15 October 2026
NCT07082452 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Methylprednisolone in Lung Diseases, Interstitial: NCT07077486 Clinical Landscape Report 2026
9 min read
Methylprednisolone in Lung Diseases, Interstitial: NCT07077486 Clinical Landscape Report 2026
15 October 2026
NCT07077486 clinical landscape for Lung Diseases, Interstitial: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Anti-BCMA-CD19 CAR-T cells(Chinese PLA General Hospital) in Plasma Cell Neoplasms: NCT07077330 Clinical Landscape Report 2026
9 min read
Anti-BCMA-CD19 CAR-T cells(Chinese PLA General Hospital) in Plasma Cell Neoplasms: NCT07077330 Clinical Landscape Report 2026
15 October 2026
NCT07077330 clinical landscape for Plasma Cell Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
NK510 in Systemic Lupus Erythematosus: NCT07083349 Clinical Landscape Report 2026
9 min read
NK510 in Systemic Lupus Erythematosus: NCT07083349 Clinical Landscape Report 2026
15 October 2026
NCT07083349 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
BRM-1420 in Relapsing acute myeloid leukemia: NCT07084584 Clinical Landscape Report 2026
9 min read
BRM-1420 in Relapsing acute myeloid leukemia: NCT07084584 Clinical Landscape Report 2026
15 October 2026
NCT07084584 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →